Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
CLINICAL CHEMICAL ANALYZERS AND REAGENTS is a federal award for Defense Health Agency held by Ortho-Clinical Diagnostics, Inc. Estimated value $3.3M ($2.1M obligated). Current period of performance ends Sep 30, 2026 (potential Jun 29, 2028). Last award drew 5 bidders. Place of performance: JACKSONVILLE VT. Related solicitation HT940622Q0002.
Recompete timing
PublicCurrent PoP ended Sep 30, 2026 (1 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT940623F0025? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT940623F0025?
HT940623F0025 (Clinical chemical analyzers and reagents) is a Defense Health Agency award with a potential value of $3.3M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9406-23-F-0025?
HT9406-23-F-0025 is the dashed form of PIID HT940623F0025 (Clinical chemical analyzers and reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT940623F0025?
Defense Health Agency awarded HT940623F0025 to Ortho-Clinical Diagnostics, Inc (potential $3.3M).
Who is the incumbent on HT940623F0025?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Ortho-Clinical Diagnostics, Inc’s HT940623F0025 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT940623F0025? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.